Mast Therapeutics, Inc. (NYSE: MSTX), announced that the Journal of Clinical Investigation (JCI) published positive interim results from an ongoing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE